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Abstract
RNases are enzymes that cleave RNAs, resulting in remarkably diverse biological consequences.
Many RNases are cytotoxic. In some cases, they attack selectively malignant cells triggering an
apoptotic response. A number of eukaryotic and bacterial RNase-based strategies are being
developed for use in anticancer and antiviral therapy. However, the physiological functions of
these  RNases  are  often  poorly  understood.  This  review  focuses  on  the  properties  of  the
extracellular  RNases  from  Bacillus  amyloliquefaciens  (barnase)  and  Bacillus  intermedius
(binase), the characteristics of their biosynthesis regulation and their physiological role, with an
emphasis on the similarities and differences. Barnase and binase can be regarded as molecular
twins according to their  highly similar structure, physical-chemical and catalytic properties.
Nevertheless, the 'life paths' of these enzymes are not the same, as their expression in bacteria
is  controlled  by  diverse  signals.  Binase  is  predominantly  synthesized  under  phosphate
starvation,  whereas barnase production is  strictly  dependent  on the multifunctional  Spo0A
regulator controlling sporulation, biofilm formation and cannibalism. Barnase and binase also
have some distinctions in practical applications. Barnase was initially suggested to be useful in
research  and  biotechnology  as  a  tool  for  studying  protein-protein  interactions,  for  RNA
elimination from biological samples, for affinity purification of RNase fusion proteins, for the
development of cloning vectors and for sterility acquisition by transgenic plants. Binase, as later
barnase, was tested for antiviral, antitumour and immunogenic effects. Both RNases have found
their own niche in cancer research as a result of success in targeted delivery and selectivity
towards tumour cells. A number of eukaryotic and bacterial RNase-based strategies are being
developed for use in anticancer and antiviral therapy. However, the physiological functions of
these RNases are often poorly understood. Barnase and binase can be regarded as molecular
twins according to their highly similar structural, physical-chemical and catalytic properties.
Nevertheless, their expression in bacteria is controlled by diverse signals. © 2011 FEBS.
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